搜尋
IQVIA Holdings Inc
IQV添加自選
185.635USD
+14.355+8.38%
收盤 06/24, 16:00（美東）報價延遲15分鐘
30.98B總市值
22.86本益比TTM
關鍵數據
174.850今開
187.790最高
1.86M成交量
22.86本益比TTM
13.06本益比動
--股利TTM
1.12%換手率
171.280昨收
174.850最低
178.26M成交額
22.57本益比靜
4.98市淨率
0.00%股息率 TTM
4.87%ROA
247.04552週最高
0.90量比
1.37B淨利潤
166.90M總股本
8.1215每股盈餘TTM
1.21Beta
22.71%ROE
136.41052週最低
7.55%振幅
25.70%毛利率
30.98B總市值
2.51回報/風險
2.28%風險率
TradingKey IQVIA Holdings Inc股票評分
單位: USD 更新時間: 2026-06-24操作建議
IQVIA Holdings Inc當前公司基本面數據相對穩定，增長潛力很大。當前估值合理，在生物技術與醫療研究行業排名1/388位。機構持股佔比非常高，近一月多位分析師給出公司評級為買入。最高目標價為228.36。中期看，股價處於上升通道。近一個月，市場表現較強，技術面和基本面綜合得分較高，較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間，可以做區間波段操作。
IQVIA Holdings Inc評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
看空
IQVIA Holdings Inc亮點
亮點風險
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
行業龍頭
公司營業收入處於行業前列，最新年度總收入16.31B美元
估值低估
公司最新PE估值22.86，處於3年歷史低位
機構減倉
最新機構持股173.06M股，環比減少5.25%
大衛赫羅持倉
明星投資者大衛赫羅持倉，最新持倉12.56M股
分析師目標
基於
25
分析師
買入
評級
228.356
目標均價
+36.11%
漲幅空間
數據免責聲明：分析師評級與目標價由LSEG提供，僅供參考，不應當作投資建議
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
IQVIA Holdings Inc簡介
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
公司代碼IQV
公司IQVIA Holdings Inc
CEOBousbib (Ari)
網址https://ir.iqvia.com/
相關品種
+0.90%
+0.82%
+0.08%
-0.14%
+0.88%
+0.83%
+1.27%
-0.02%
+0.09%
-2.71%
+1.45%
-0.89%
-1.86%
-0.65%
+0.41%
0.00%
+0.87%
+1.80%
-0.11%
-0.76%熱門品種
51867.400
-104.300 (-0.20%)
29734.400
-59.800 (-0.20%)
7401.000
-9.400 (-0.13%)
15791.000
+254.000 (+1.64%)
72030.000
+1073.000 (+1.51%)
6215.900
-12.300 (-0.20%)
69.314
-0.445 (-0.64%)
293.080
-1.220 (-0.41%)
199.000
-1.040 (-0.52%)
3993.990
-4.750 (-0.12%)
常見問題
IQVIA Holdings Inc(IQV)的當前股價是多少？
IQVIA Holdings Inc(IQV)的當前股價是 185.63。
IQVIA Holdings Inc 的股票代碼是什麼？
IQVIA Holdings Inc的股票代碼是IQV。
IQVIA Holdings Inc股票的52週最高點是多少？
IQVIA Holdings Inc股票的52週最高點是247.04。
IQVIA Holdings Inc股票的52週最低點是多少？
IQVIA Holdings Inc股票的52週最低點是136.41。
IQVIA Holdings Inc的市值是多少？
IQVIA Holdings Inc的市值是30.98B。
現在IQVIA Holdings Inc(IQV)的股票是買入、持有還是賣出？
根據分析師評級，IQVIA Holdings Inc(IQV)的總體評級為買入，目標價格為228.36。
IQVIA Holdings Inc(IQV)股票的每股收益（EPS TTM）是多少
IQVIA Holdings Inc(IQV)股票的每股收益（EPS TTM）是7.91。
